Sale!

P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test” is a specialized diagnostic procedure designed to identify mutations in the P2RY12 gene, which are associated with Platelet-Type 8 Bleeding Disorder. This condition is characterized by a defect in platelet function, leading to an increased risk of bleeding. The P2RY12 gene plays a crucial role in the activation of platelets, which are essential for blood clotting. Mutations in this gene can impair platelet function, resulting in symptoms ranging from mild to severe bleeding episodes.

The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. By analyzing a patient’s DNA, the test can detect specific mutations in the P2RY12 gene that are responsible for the disorder. This information is critical for the accurate diagnosis and management of affected individuals, enabling healthcare providers to tailor treatment plans that may include preventive measures against bleeding and recommendations for lifestyle adjustments.

The cost of the P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers invaluable insights into the genetic basis of the patient’s condition, facilitating a proactive approach to managing the disorder and improving the patient’s quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test

Test Name: P2RY12 Gene Bleeding Disorder Platelet-Type 8 Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for P2RY12 Gene Bleeding Disorder, Platelet-Type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with P2RY12 Gene Bleeding Disorder, Platelet-Type 8 NGS Genetic DNA Test gene P2RY12.

Test Details: The P2RY12 gene is responsible for producing a protein called P2Y12 receptor, which is found on the surface of platelets. Platelets are small blood cells that play a crucial role in blood clotting. When a blood vessel is damaged, platelets adhere to the site and form a plug to stop bleeding. However, mutations in the P2RY12 gene can lead to a bleeding disorder known as platelet-type 8. This condition is characterized by abnormal platelet function, resulting in an increased risk of bleeding and difficulty in forming blood clots.

To diagnose platelet-type 8, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the P2RY12 gene. This test involves extracting DNA from a blood sample and sequencing the P2RY12 gene to identify any genetic variants or mutations.

NGS genetic testing for platelet-type 8 can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It can also be useful for identifying carriers of the gene mutation within families.

Treatment for platelet-type 8 may involve medications that inhibit platelet function, such as aspirin or clopidogrel. In severe cases, platelet transfusions may be necessary to control bleeding episodes.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate counseling and guidance based on the test results.

Test Name P2RY12 Gene Bleeding disorder platelet-type 8 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for P2RY12 Gene Bleeding disorder, platelet-type 8 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with P2RY12 Gene Bleeding disorder, platelet-type 8 NGS Genetic DNA Test gene P2RY12
Test Details

The P2RY12 gene is responsible for producing a protein called P2Y12 receptor, which is found on the surface of platelets. Platelets are small blood cells that play a crucial role in blood clotting. When a blood vessel is damaged, platelets adhere to the site and form a plug to stop bleeding.

However, mutations in the P2RY12 gene can lead to a bleeding disorder known as platelet-type 8. This condition is characterized by abnormal platelet function, resulting in an increased risk of bleeding and difficulty in forming blood clots.

To diagnose platelet-type 8, a Next-Generation Sequencing (NGS) genetic test can be performed. NGS is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes, including the P2RY12 gene. This test involves extracting DNA from a blood sample and sequencing the P2RY12 gene to identify any genetic variants or mutations.

NGS genetic testing for platelet-type 8 can help confirm a diagnosis, guide treatment decisions, and provide information about the inheritance pattern of the condition. It can also be useful for identifying carriers of the gene mutation within families.

Treatment for platelet-type 8 may involve medications that inhibit platelet function, such as aspirin or clopidogrel. In severe cases, platelet transfusions may be necessary to control bleeding episodes.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics, as they can provide appropriate counseling and guidance based on the test results.